The GREThA (UMR CNRS 5113), a laboratory of Theoretical and Applied Research in Economics at the University of Bordeaux, will hold a one-day conference on June 6^th. I will present our last NBER working paper on Orphan Drug and IPO investors in Pharma-Biotech.